VLPbio

Recent Finacing

Equity

Recent Raise

$1M

VLPbio develops veterinary vaccines using a patented chimeric pseudoviral particle platform that presents specific antigens without infectious material, enabling DIVA capability and application across poultry, bovine, and swine.

Founded 2011

Castilla y Leon, Spain

1-10

Private

vlpbio.com

Highlights

Focus Areas

Biotechnology

Health Care

Hospital

Medical

Medical Device

Recent Investors

Financials

$1M

Total Raised

1

Funding round

2

Investors

Team

Upgrade to view the team

See the team members at VLPbio.